All In Biotech

Drug Trial Radar · NCT07396337

Study to Assess the Efficacy and Safety of QHRD106 Injection in Acute Ischemic Stroke.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Trial of QHRD106 Injection for the Treatment of Acute Ischemic Stroke

Last checked: Nov 19, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Jan 19, 2026

Primary completion

Oct 31, 2026

Study completion Dec 31, 2026

Sponsor

Sponsor type
Industry
First posted
Feb 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the efficacy and safety of QHRD106 injection in treating acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke

Interventions

  • QHRD106 Injection (Low-dose group)Drug

    Participants will receive QHRD106 injection (5600 IU) every 7 days with a total of 3 doses.

  • QHRD106 Injection (Middle-dose group)Drug

    Participants will receive QHRD106 injection (8400 IU) every 7 days with a total of 3 doses.

  • QHRD106 Injection (High-dose group)Drug

    Participants will receive QHRD106 injection (12600 IU) every 7 days with a total of 3 doses.

  • PlaceboDrug

    Participants will receive placebo every 7 days with a total of 3 doses.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. modified rankin scale (mRS) score ≤ 1Time frame: Day 90 after randomization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nanjing Drum Tower Hospital

    Nanjing, Jiangsu, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.